Table 2.
Mean | SD | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. Cooperative Communication | 2.50 | 0.84 | ---- | .29** | 27** | 24** | .22* | −.05 | −.03 | .30** | −.02 | −.11 | −.01 | .26** | .20* |
2. Adolescent-rated family functioninga | 2.53 | 0.31 | ---- | .49*** | .26** | .03 | −.12 | .06 | .07 | −.01 | −.16+ | .03 | .01 | −.07 | |
3. Parent-rated family functioningb | 2.61 | 0.29 | ---- | .30** | −.06 | −.09 | .06 | .09 | −.05 | −.13 | .02 | −.01 | −.03 | ||
4. Income-to-needs ratio | 2.07 | 1.45 | ---- | .44*** | −.004 | −.007 | .35*** | .07 | −.10 | −.10 | .08 | .25** | |||
5. Racec | 0.31 | 0.46 | ---- | .13 | −.08 | .46*** | .05 | .09 | −.10 | .15 | .36*** | ||||
6. Age | 14.96 | 1.66 | ---- | −.04 | .10 | −.05 | .18* | .04 | .15 | .18+ | |||||
7. Genderd | 0.17 | 0.38 | ---- | −.09 | −.01 | −.18* | .002 | −.12 | −.003 | ||||||
8. Medicatione | 0.27 | 0.45 | ---- | .04 | .26** | .30** | .38*** | .37*** | |||||||
9. Treatment conditionf | 0.52 | 0.50 | ---- | .07 | .03 | −.01 | −.09 | ||||||||
10. Baseline BDI | 35.62 | 9.30 | ---- | .41*** | .46*** | .33*** | |||||||||
11. Baseline SIQ | 49.89 | 15.16 | ---- | .22* | .28** | ||||||||||
12. Week 16 BDI | 18.13 | 14.08 | ---- | .70*** | |||||||||||
13. Week 16 SIQ | 20.89 | 16.80 | ---- |
Note:
aggregated adolescent-rated family conflict (M = 2.18, SD = 0.67), reverse coded, and cohesion (M = 2.87, SD = 0.67);
aggregated parent-rated family conflict (M = 2.16, SD = 0.47), reverse coded, and cohesion (M = 3.06 SD = 0.61);
1 = white, 0 = non-white;
1 = male, 0 = female;
1 = currently on anti-depressant medication, 0 = not currently on anti-depressant medication;
1 = ABFT, 0 = FE-NST;
p < .10;
p < .05;
p < .01;
p < .001